Stay updated on TAK-935 in Pediatric Developmental/Epileptic Encephalopathies Clinical Trial

Sign up to get notified when there's something new on the TAK-935 in Pediatric Developmental/Epileptic Encephalopathies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TAK-935 in Pediatric Developmental/Epileptic Encephalopathies Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    No visible additions or deletions detected between the two screenshots; the page content appears unchanged.
    Difference
    0.1%
    Check dated 2026-04-11T10:28:15.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    No substantive content changes detected between the screenshots; the page content appears unchanged.
    Difference
    0.1%
    Check dated 2026-04-04T05:25:01.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Severe myoclonic epilepsy in infancy and Tuberous sclerosis syndrome were added, while Dravet syndrome and Tuberous sclerosis were removed. This appears to be terminology/keyword adjustments rather than a change to the study design or eligibility.
    Difference
    0.1%
    Check dated 2026-03-27T23:47:35.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Added revision label v3.5.0 and removed revision label v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-20T20:20:20.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    No additions or deletions were detected on the page.
    Difference
    0.1%
    Check dated 2026-03-13T21:32:41.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-06T18:22:07.000Z thumbnail image

Stay in the know with updates to TAK-935 in Pediatric Developmental/Epileptic Encephalopathies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TAK-935 in Pediatric Developmental/Epileptic Encephalopathies Clinical Trial page.